로딩 중…
지수 로딩 중…
Adaptive Biotechnologies Corporation
ADPT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$17.53+4.47%
2026-06-18
Price Chart
Adaptive Biotechnologies Corporation+67.43%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.81B |
| Revenue | $295M |
| Net Income | $-50M |
| Total Assets | $506M |
| Net Assets | $216M |
| Value | |
| P/B | 12.97x |
| P/S | 9.50x |
| FCF Yield | -1.05% |
| Profitability | |
| ROE | -22.96% |
| ROA | -9.82% |
| Op. Margin | -15.82% |
| Revenue Growth | 35.14% |
| Financial Health | |
| Debt Ratio | 130.21% |
| Total Debt | $208M |
| FCF | $-30M |
| Cash | $78M |
| Current Ratio | 3.35x |
| Performance | |
| 1Y Return | 67.43% |
| 1M Return | 35.26% |
| From 52W High | -15.56% |
| 1Y MDD | -39.35% |
| Trading | |
| Volume | 3,742,834 shares |
| Trading Value | $65M |
| Per Share | |
| EPS | $-0.39 |
| BPS | $1.43 |